Publication Topic

Suh M, Jiang X, Movva N, Fryzek J, Bylsma L, Rizzo C, Nelson CB. Hospitalizations and emergency department visits for respiratory syncytial virus among infants aged <1 year in the United States: An analysis of nationwide inpatient and emergency room data. Presentation to IDWeek Virtual Conference on Infectious Disease, October 2020.

Rankin DA, Haddadin Z, Lipworth L, Fryzek J, Suh M, Shepard DS, McHenry R, Varjabedian R, et al. Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings. IDWeek Virtual Conference on Infectious Disease, October 2020.

Shepard DS, Perloff J, Jiang X, Suh M, Fryzek J, Bowser D, Rizzo C, Nelson CB. Impacts of age and season on rates of hospitalization for respiratory syncytial virus (RSV) in infants in the United States and their use of mechanical ventilation and charges. IDWeek Virtual Conference on Infectious Disease, October 2020.

Flythe JE, Hilliard TS, Ikeler K, Keller S, Gipson DS, Grandinetti AC, Nordyke RJ, Perrone RD, et al. 2020. Toward patient-centered innovation: A conceptual framework for patient-reported outcome measures for transformative kidney replacement devices. Clin J Am Soc Nephrol 15(10):1522-1530; doi: 10.2215/CJN.00110120. PMID: 32276947.

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. 2020. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States. J Med Econ 23(8):902-907; doi: 10.1080/13696998.2020.1764006. PMID: 32362156.

Gage SM, Reichert H. 2020. Determining the incidence of needle-related complications in hemodialysis access: We need a better system. J Vasc Access 22(4):521-532; doi: 10.1177/1129729820946917. PMID: 32811335.

Dean R, Arjunji R, Awano H, Igarash A^, Tanaka A, Jensen IS, Cyr PL, Miller B, et al. Cost-effectiveness of onasemnogene abeparvocec (ZOLGENSMA) for spinal muscular atrophy type 1 against nusinersen in Japan. ISPOR 25th Annual International Meeting, Orlando FL, 2020.

Sacks NC, Healey B, Cyr PL, Graham R. Economic burden of X-linked myotubular myopathy (XLMTM) by ventilation status. ISPOR 25th Annual International Meeting, Orlando FL, 2020.

Hathway J, Miller-Wilson L, Jensen I, Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123. PMID: 32063100.

Dean R, Miller B, Arjunji R, Awano H, Igarashi A, Tanaka S, Feltner DE, Sproule DM, Jensen I, Dabbous O. 2020. Abstract PMU36: Cost-utility analysis of single dose gene-replacement therapy for spinal muscular atrophy type 1 compared to chronic nusinersen treatment in Japan. Value in Health 23(Sup 1):S239; doi: 10.1016/j.val.2020.04.810.